Syndecan-1 (CD 138) surface expression marks cell type and differentiation in ameloblastoma, keratocystic odontogenic tumor, and dentigerous cyst

被引:18
|
作者
Al-Otaibi, Ohoud [1 ]
Khounganian, Rita [1 ]
Anil, Sukumaran [2 ]
Rajendran, Ravindranath [1 ]
机构
[1] King Saud Univ, Coll Dent, Dept Oral Med & Diagnost Sci, Riyadh 11545, Saudi Arabia
[2] King Saud Univ, Coll Dent, Dept Periodont & Community Dent, Riyadh 11545, Saudi Arabia
关键词
bone disease; cyst; odontogenic tumor; HEPARAN-SULFATE PROTEOGLYCANS; MEMBRANE; KI-67; TRANSFORMATION; MOLECULES; CARCINOMA; PROTEIN;
D O I
10.1111/j.1600-0714.2012.01195.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: The altered expression of syndecan-1 (SD-1), a transmembrane heparan sulfate proteoglycan, in ameloblastomas and cysts of odontogenic origin suggests that this molecule could have prognostic value in assessing the clinical outcome of those lesions. The purpose of this study was to analyze SD-1 expression profile immunohistochemically in archival, paraffin-embedded tissue sections of ameloblastomas and in common odontogenic cysts arising from the same locale. Methods: SD-1 expression was investigated in 32 ameloblastomas, 26 keratocystic odontogenic tumors (KCOT), and 21 dentigerous cysts from the archives of the histopathology laboratory which were routinely processed. The cases were reviewed and assessed according to the established criteria. Sections were immunostained with monoclonal antibody against SD-1 (CD138). Sections of normal oral mucosa, site matched, were stained in parallel as positive controls. The plasma cells in sections served as internal positive controls. Results: SD-1 expression was observed in the epithelial and stromal elements of the sections, and the expression was significantly associated with the lesion's extension and involvement of adjacent structures (P=0.025). Stellate-reticulum cells showed higher expression than the ameloblasts, which was at a significant level (P<0.0001). Highly significant difference was reported among the three groups of lesion for the epithelial staining (P<0.0001). The mean rank scores (KruskalWallis test) of ameloblastomas were significantly lower than those of KCOT and dentigerous cysts. Non-significant comparison was made between KCOT and dentigerous cyst groups. Conclusions: The present study revealed SD-1 immunoreactivity in the stromal cells of ameloblastoma, KCOT, and dentigerous cysts rather uniformly. This reported SD-1 expression by the tumor stroma is considered to be associated with poor prognosis of the lesions. J Oral Pathol Med (2013)42: 186-193
引用
收藏
页码:186 / 193
页数:8
相关论文
共 50 条
  • [21] Differential expression of syndecan-1 (CD138) in myxoid soft tissue tumors
    Liu, J.
    Haupt, H. M.
    Brooks, J. J.
    LABORATORY INVESTIGATION, 2007, 87 : 18A - 18A
  • [22] Syndecan-1 (CD 138) in myeloma and lymphoid malignancies: A multifunctional regulator of cell behavior within the tumor microenvironment
    Dhodapkar, MV
    Sanderson, RD
    LEUKEMIA & LYMPHOMA, 1999, 34 (1-2) : 35 - 43
  • [23] The Intensity and Pattern of Syndecan-1 (CD138) Expression in Normal and Diseased Livers
    Atique, Muhammad
    Javed, Rabia
    Seerat, Iqtadar
    Atique, Usman
    Bhatti, Tayyaba
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [24] Syndecan-1 (CD138) expression in human non-Hodgkin lymphomas
    Sebestyén, A
    Berczi, L
    Mihalik, R
    Paku, S
    Matolcsy, A
    Kopper, L
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 104 (02) : 412 - 419
  • [25] Role of syndecan-1 (CD138) in cell survival of human urothelial carcinoma
    Shimada, Keiji
    Nakamura, Mitsutoshi
    De Velasco, Marco A.
    Tanaka, Motoyoshi
    Ouji, Yukiteru
    Miyake, Makito
    Fujimoto, Kiyohide
    Hirao, Kazuya
    Konishi, Noboru
    CANCER SCIENCE, 2010, 101 (01) : 155 - 160
  • [26] Comparative analysis of the immunohistochemical expression of vascular endothelial growth factor and matrix metalloproteinase-9 in keratocystic odontogenic tumor, dentigerous cyst and radicular cyst
    Khot, Komal
    Deshmukh, Siddharth B.
    Alex, Sheeba
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (03) : 635 - 640
  • [27] Syndecan-1 (CD138) expression in human non-Hodgkin's lymphomas
    Sutcliffe, M
    Oscier, D
    Wright, DH
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (01) : 239 - 240
  • [28] Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas
    Bologna-Molina, R.
    Mosqueda-Taylor, A.
    Lopez-Corella, E.
    Almeida, O. P.
    Carrasco-Daza, D.
    Garcia-Vazquez, F.
    Farfan-Morales, J. E.
    Irigoyen-Camacho, M. E.
    Damian-Matsumura, P.
    ORAL ONCOLOGY, 2008, 44 (08) : 805 - 811
  • [29] Expression of Syndecan-1 (CD138) in Bladder Cancer with Emphasis on Conventional Urothelial Carcinoma and Urothelial Carcinoma with Squamous Differentiation
    Patel, S.
    Osunkoya, A. O.
    Ormenisan, C.
    Oprea-Ilies, G. M.
    MODERN PATHOLOGY, 2012, 25 : 234A - 234A
  • [30] Expression of Syndecan-1 (CD138) in Bladder Cancer with Emphasis on Conventional Urothelial Carcinoma and Urothelial Carcinoma with Squamous Differentiation
    Patel, S.
    Osunkoya, A. O.
    Ormenisan, C.
    Oprea-Ilies, G. M.
    LABORATORY INVESTIGATION, 2012, 92 : 234A - 234A